Category: Diseases & Conditions
Diseases & Conditions market research reports by IMARC Services Pvt. Ltd.
-
Australia Skin Treatment Market Report by Product Type (Chemical Peels, Microdermabrasion, Micro Needling Treatments, Traditional Beauty Treatments), Gender (Male, Female), Application (Acne, Atopic Dermatitis, Hyperpigmentation, Psoriasis, Deep Wrinkles, Freckles, Melasma, and Others), End-User (Clinics and Hospitals, Medical Spas and Salons, At-home), and Region 2025-2033
The Australia skin treatment market size reached USD 364.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 496.8 Million by 2033, exhibiting a growth rate (CAGR) of 3.32% during 2025-2033. The rising awareness among individuals about skin treatment options, wide availab ... Read More
-
Thailand Medical Cannabis Market Report by Cultivated Species (Indica, Sativa, Hybrid), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC), and Others), Application Areas (Cancer, Arthritis, Migraine, Epilepsy, and Others), End-Use (Pharmaceuticals, Research and Development Centres, and Others), Route of Administration (Oral Solutions and Capsules, Vaporizers, Topicals, and Others) 2025-2033
The Thailand medical cannabis market size reached USD 274.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 7,544.0 Million by 2033, exhibiting a growth rate (CAGR) of 44.5% during 2025-2033. The market is propelled by the favorable government regulatory framework, wide ... Read More
-
Behavioral Mental Health Care Software Market Report by Solution (Software, Services), Function (Clinical Functionality, Administrative Functionality, Financial Functionality), Disorder Type (Anxiety, Post-Traumatic Stress Disorder (PSTD), Substance Abuse, Schizophrenia, Bipolar Disorders, and Others), Delivery Model (Subscription Model, Ownership Model), End Use (Providers, Payers, Patients), and Region 2025-2033
The global behavioral mental health care software market size reached USD 4.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 10.1 Billion by 2033, exhibiting a growth rate (CAGR) of 10.11% during 2025-2033. The growth of the market is driven by the increasing advent of ... Read More
-
Cancer Cachexia Market Report by Therapeutics (Progestogens, Corticosteroids, Combination Therapy, and Others), Mode of Action (Appetite Stimulators, Weight Loss Stabilizers), Distribution Channel (Hospital Stores, Retail Pharmacy, Online Pharmacy), and Region 2025-2033
The global cancer cachexia market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.0 Billion by 2033, exhibiting a growth rate (CAGR) of 3.9% during 2025-2033. The market is driven by the rising global cancer incidence, the growing recognition of c ... Read More
-
Cancer Vaccines Market Report by Type, (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Viral Vector and DNA Cancer Vaccines, Whole-cell Cancer Vaccines), Indication (Cervical Cancer, Prostate Cancer, and Others), End User (Pediatrics, Adults), and Region 2025-2033
The global cancer vaccines market size reached USD 7.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 19.1 Billion by 2033, exhibiting a growth rate (CAGR) of 9.73% during 2025-2033. The increasing cancer incidence, advancements in immunotherapy, government initiatives ... Read More
-
Liver Disease Treatment Market Report by Treatment Type (Antiviral Drugs, Immunosuppressants, Vaccines, Immunoglobulins, Corticosteroids, Targeted Therapy, Chemotherapy), Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Region 2025-2033
The global liver disease treatment market size reached USD 25.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 40.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.44% during 2025-2033. The growing elderly population worldwide, which is prone to several chronic i ... Read More
-
Autoinjector Market Report by Type (Disposable Autoinjectors, Reusable Autoinjectors), Application (Rheumatoid Arthritis, Anaphylaxis, Multiple Sclerosis, and Others), End User (Home Care Settings, Hospitals and Clinics), and Region 2025-2033
The global autoinjector market size reached USD 2.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.2 Billion by 2033, exhibiting a growth rate (CAGR) of 13.19% during 2025-2033. The increasing prevalence of chronic diseases, continuous advancements in biologics and b ... Read More
-
Veterinary Pain Management Market Report by Product (Drugs, Devices), Animal Type (Companion, Livestock), Application (Osteoarthritis and Joint Pain, Postoperative Pain, Cancer, and Others), End User (Hospitals and Clinics, and Others), and Region 2025-2033
The global veterinary pain management market size reached USD 1.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.63% during 2025-2033. There are several factors that are driving the market, which include the ris ... Read More
-
Dengue Testing Market Report by Test Type (ELISA-based Tests, RT-PCR based Tests, Dengue IgG/IgM Rapid Test, and Others), End User (Hospitals, Diagnostic Centers, and Others), and Region 2025-2033
The global dengue testing market size reached USD 610.8 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 911.7 Million by 2033, exhibiting a growth rate (CAGR) of 4.32% during 2025-2033. The market is primarily driven by the increasing dengue fever prevalence worldwide, ... Read More
-
In-vitro Colorectal Cancer Screening Tests Market Report by Product (Fecal Occult Blood Tests, Biomarker Tests, CRC DNA Screening Tests), Imaging Type (Colonoscopy, Proctoscopy, CT Scan, Ultrasound, MRI, PET Scan), End User (Hospitals, Clinics, Diagnostic Laboratories, and Others), and Region 2025-2033
The global in-vitro colorectal cancer screening tests market size reached USD 1,049.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,658.7 Million by 2033, exhibiting a growth rate (CAGR) of 4.96% during 2025-2033. In-vitro colorectal cancer screening tests are diagn ... Read More
-
Neuromodulation Market Report by Technology (Internal Neuromodulation, External Neuromodulation), Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials), Application (Parkinson's Disease, Epilepsy, Depression, Dystonia, Pain Management, and Others), and Region 2025-2033
The global neuromodulation market size reached USD 8.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 18.8 Billion by 2033, exhibiting a growth rate (CAGR) of 9.2% during 2025-2033. The market is experiencing robust growth, driven by the increasing prevalence of chroni ... Read More
-
In-vivo CRO Market Report by Type (Rodent, Non-Rodent), GLP Type (Non-GLP, GLP Toxicology), Indication (Autoimmune/Inflammation Conditions, Pain Management, Oncology, CNS Conditions, Diabetes, Obesity, and Others), and Region 2025-2033
The global in-vivo CRO market size reached USD 5.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.8 Billion by 2033, exhibiting a growth rate (CAGR) of 6.76% during 2025-2033. The growing prevalence of chronic diseases worldwide and the increasing R&D expenditure by ... Read More
-
Clinical Nutrition Market Report by Product (Infant Nutrition, Parental Nutrition, Enteral Nutrition), Route of Administration (Oral, Enteral, Parenteral), Application (Cancer, Malnutrition, Metabolic Disorders, Gastrointestinal Disorders, Neurological Disorders, and Others), End User (Pediatric, Adults, Geriatric), and Region 2025-2033
The global clinical nutrition market size reached USD 55.8 Billion in 2024. Looking forward, the market is expected to reach USD 104.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.2% during 2025-2033. There are various factors that are driving the market, which include increasing prevalence ... Read More
-
Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2025-2033
The global biomarkers market size reached USD 89.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 249.4 Billion by 2033, exhibiting a growth rate (CAGR) of 10.8% during 2025-2033. The rising prevalence of chronic diseases, ongoing developments in biotechnology and geno ... Read More
-
Prostate Cancer Treatment Market Report by Drug Type (Chemotherapy, Biological Therapy, Hormone Therapy, and Others), Distribution Channel (Hospitals Pharmacies, Drug Stores and Retail Pharmacies, Online Pharmacies), and Region 2025-2033
The global prostate cancer treatment market size reached USD 8.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 12.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.9% during 2025-2033. The increasing prevalence of the disease, advancements in personalized medici ... Read More
-
Women's Health Diagnostics Market Report by Type (Diagnostic Devices, Diagnostic Tests), Application (Breast Cancer, Infectious Disease Testing, Osteoporosis Testing, Pregnancy and Fertility Testing, Sexually Transmitted Disease Testing, and Others), End User (Hospital and Diagnostics Centers, Home Care), and Region 2025-2033
The global women's health diagnostics market size reached USD 31.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 54.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.4% during 2025-2033. The market is propelled by the rising number of individuals diagnosed with ... Read More
-
Prenatal and Newborn Genetic Testing Market Report by Product Type (Consumables, Instruments), Screening (Non-invasive Prenatal Testing, Chorionic Villus Sampling, Amniocentesis, Maternal Serum Screening), Disease (Downs Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia), End User (Hospital, Maternity and Specialty Clinics, Diagnostic Centers), and Region 2025-2033
The global prenatal and newborn genetic testing market size reached USD 6.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 17.3 Billion by 2033, exhibiting a growth rate (CAGR) of 11.04% during 2025-2033. The market share is experiencing steady growth driven by the gro ... Read More
-
Non-Alcoholic Steatohepatitis (NASH) Market by Drug Type (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib, Cenicriviroc, and Others), Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), Sales Channel (Hospital Pharmacy, Online Providers, Retail Pharmacy), End User (Hospitals, Clinics, Homecare Settings), and Region 2025-2033
The global non-alcoholic steatohepatitis (NASH) market size reached USD 1.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 13.5 Billion by 2033, exhibiting a growth rate (CAGR) of 22.97% during 2025-2033. The rising prevalence of NASH, increasing awareness regarding ea ... Read More
-
Anti-Tuberculosis Therapeutics Market Report by Disease Type (Active TB, Latent TB, and Others), Diagnosis and Treatment (Diagnosis, Treatment), End User (Hospitals, Specialty Clinics, Homecare, and Others), and Region 2025-2033
The global anti-tuberculosis therapeutics market size reached USD 1,530.1 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 2,552.2 Million by 2033, exhibiting a growth rate (CAGR) of 5.56% during 2025-2033. The rising healthcare spending, favorable reimbursement policies ... Read More
-
Viscosupplementation Market by Type (Single Injection, Three Injection, Five Injection), Age Group (Adults, Geriatrics), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), Application (Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis, and Others), End Use (Hospitals, Orthopedic Clinics, and Others), and Region 2025-2033
The global viscosupplementation market size reached USD 4.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.05% during 2025-2033. The increasing prevalence of osteoporosis and osteoarthritis (OA) and the shifting ... Read More
-
Systemic Lupus Erythematosus (SLE) Drugs Market by Drug Class (Antimalarials Drugs, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Cytotoxic and Immunosuppressive Drugs, Biologics, and Others), Mode of Delivery (Intravenous, Subcutaneous, Oral), and Region 2025-2033
The global systemic lupus erythematosus (SLE) drugs market size reached USD 2.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.7 Billion by 2033, exhibiting a growth rate (CAGR) of 5.54% during 2025-2033. The increasing number of patients suffering from SLE, rising p ... Read More
-
Respiratory Diagnostics Market Report by Product and Service Type (Instruments and Services, Assays and Reagents, Services and Software), Test Type (Mechanical Tests, Obstructive Sleep Apnoea (OSA) Diagnostic Tests, Imaging Tests, Traditional Diagnostic Tests, Molecular Diagnostic Tests, and Others), Disease (Tuberculosis, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Lung Cancer, and Others), End-User (Hospitals, Clinics, Reference and Clinical Laboratories, and Others), and Region 2025-2033
The global respiratory diagnostics market size reached USD 8.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 15.5 Billion by 2033, exhibiting a growth rate (CAGR) of 6.43% during 2025-2033. The growing prevalence of respiratory diseases, rising healthcare expenditure, ... Read More
-
Hepatitis Diagnostic Tests Market Report by Test Type (Blood Tests, Imaging Test, Liver Biopsy), and Region 2025-2033
The global hepatitis diagnostic tests market size reached USD 6.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 9.0 Billion by 2033, exhibiting a growth rate (CAGR) of 4.23% during 2025-2033. The market is experiencing robust growth, driven by the rising prevalence of ... Read More
-
Cardiac Biomarkers Market Report by Type (Troponins (T and I), Myocardial Muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), and Others), Location of Testing (Laboratory Testing, Point of Care Testing), Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), and Region 2025-2033
The global cardiac biomarkers market size reached USD 11.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.2 Billion by 2033, exhibiting a growth rate (CAGR) of 7.22% during 2025-2033. Cardiac markers, also known as cardiac biomarkers, are released into the bloodstre ... Read More
-
H1N1 Vaccines Market Report by Vaccine Type (Intramuscular, Intranasal, Intradermal), Market Type (Public, Private), and Region 2025-2033
The global H1N1 vaccines market size reached USD 3.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 5.6 Billion by 2033, exhibiting a growth rate (CAGR) of 4.03% during 2025-2033. The increasing healthcare concerns, significant medical advancements, improving healthcar ... Read More